DSC2 Gene Arrhythmogenic right ventricular cardiomyopathy type 11 Genetic Test
At DNA Labs UAE, we offer the DSC2 Gene Arrhythmogenic right ventricular cardiomyopathy type 11 Genetic Test for AED 4400.0. This test is used to diagnose and identify potential disease-causing variants or mutations in the DSC2 gene associated with arrhythmogenic right ventricular cardiomyopathy (ARVC).
Test Details
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a condition characterized by the replacement of normal heart muscle tissue with fibrous or fatty tissue in the right ventricle. This can lead to abnormal heart rhythms and potentially life-threatening arrhythmias.
Our NGS (Next-Generation Sequencing) technology allows us to analyze multiple genes simultaneously, including the DSC2 gene, to identify mutations or variants that may be responsible for the development of ARVC type 11. By analyzing the individual’s DNA, NGS testing can provide valuable information about their genetic predisposition to ARVC type 11.
Early diagnosis through genetic testing can help with risk assessment and potentially guide treatment decisions. However, it is important to note that genetic testing should always be done under the guidance of a healthcare professional who can interpret the results and provide appropriate counseling and medical management.
Test Components and Price
The DSC2 Gene Arrhythmogenic right ventricular cardiomyopathy type 11 Genetic Test is priced at AED 4400.0. The test can be conducted using a blood sample, extracted DNA, or one drop of blood on an FTA card.
Report Delivery and Method
The report for the DSC2 Gene Arrhythmogenic right ventricular cardiomyopathy type 11 Genetic Test will be delivered within 3 to 4 weeks. The test is performed using NGS technology, which allows for efficient and accurate analysis of multiple genes simultaneously.
Test Type and Doctor
The DSC2 Gene Arrhythmogenic right ventricular cardiomyopathy type 11 Genetic Test falls under the category of Cardiovascular Pneumology Disorders. It is recommended to consult with a Cardiologist for this test.
Test Department and Pre Test Information
The DSC2 Gene Arrhythmogenic right ventricular cardiomyopathy type 11 Genetic Test is conducted in our Genetics department. Before undergoing the test, it is important to provide the clinical history of the patient and participate in a Genetic Counselling session to draw a pedigree chart of family members affected by ARVC type 11.
Genetic counselling and pedigree analysis help in understanding the inheritance pattern and identifying potential carriers of the DSC2 gene mutation.
At DNA Labs UAE, we strive to provide accurate and reliable genetic testing services. Our DSC2 Gene Arrhythmogenic right ventricular cardiomyopathy type 11 Genetic Test can provide valuable insights into an individual’s genetic predisposition to ARVC type 11, aiding in early diagnosis and personalized treatment plans.
Test Name | DSC2 Gene Arrhythmogenic right ventricular cardiomyopathy type 11 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Cardiovascular Pneumology Disorders |
Doctor | Cardiologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for DSC2 Gene Arrhythmogenic right ventricular cardiomyopathy type 11 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with DSC2 Gene Arrhythmogenic right ventricular cardiomyopathy type 11 NGS Genetic DNA Test gene DSC2 |
Test Details |
The DSC2 gene is associated with arrhythmogenic right ventricular cardiomyopathy (ARVC), a condition characterized by the replacement of normal heart muscle tissue with fibrous or fatty tissue in the right ventricle. This can lead to abnormal heart rhythms and potentially life-threatening arrhythmias. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify potential disease-causing variants or mutations. In the context of ARVC type 11, NGS genetic testing can be used to identify mutations or variants in the DSC2 gene that may be responsible for the development of the condition. By analyzing the individual’s DNA, NGS testing can provide valuable information about their genetic predisposition to ARVC type 11. This can help with early diagnosis, risk assessment, and potentially guide treatment decisions. It is important to note that genetic testing should always be done under the guidance of a healthcare professional who can interpret the results and provide appropriate counseling and medical management. |